$KYTX
Kyverna Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is KYTX up today? It is at $8.45 (+3.96%), and our scanner flagged it 33 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment KYTX spikes, and full due diligence on KYTX — key stats, earnings, dilution and insider activity. Free.
Get free $KYTX alerts the moment volume spikes
Our scanner flagged $KYTX 33 times in the last 30 days. Create a free account to track $KYTX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $8.45
- Change today
- +3.96%
- Previous close
- $8.13
- 52-week range
- $3.55 – $13.67
- Market cap
- $521M
- Shares outstanding
- 61.8M SEC · as of 2026-08-03 · 20d
- Institutional own.
- 71.10%
- Total held
- 88.8%
- Tradeable float
- 6.9M 11% of shares · after 18% insiders + 71% institutions
- Short interest
- 8.2M ▲ +4% vs prior · as of 2026-07-31
- Days to cover
- 8.7d
- Avg daily volume
- 1.0M
- Sector
- Health Care
- Industry
- Biological Products, (No Diagnostic Substances)
- Exchange
- XNAS
- 5mthin
- 235x
- 15mthin
- 235x
- 1hthin
- 235x
- 1D
- --
Get free KYTX + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $KYTX up today?
Here is the latest on KYTX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for KYTX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystKyverna Therapeutics, Inc.: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →Analyst data via Nasdaq. Not investment advice.
Insiders
Insiders buying1 open-market buy4 buys, 1 sells last 3 months (12/2 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Aktar Mert Director | Acquired (grant/award) | +5K | added 31% | 22K | n/a | May 27, 26 |
Shaw Christi Officer | Sold (automatic/other) | -4K | sold 5.9% | 67K | $36K at $8.59 | May 27, 26 |
Seidenberg Beth C Director | Acquired (grant/award) | +5K | added 31% | 22K | n/a | May 27, 26 |
Cohen Fred E Director | Acquired (grant/award) | +5K | added 31% | 22K | n/a | May 27, 26 |
Clark Ian T Director | Acquired (grant/award) | +5K | added 31% | 22K | n/a | May 27, 26 |
Gehchan Naji Officer | Acquired (grant/award) | +18K 0.03% of company | n/a | 18K | n/a | Mar 13, 26 |
Biddle Warner Weston Officer | Acquired (grant/award) | +58K 0.09% of company | n/a | 58K | n/a | Mar 13, 26 |
Grasso Marc Officer | Acquired (grant/award) | +10K 0.02% of company | n/a | 10K | n/a | Mar 13, 26 |
Emany Sravan Kumar Director | Acquired (grant/award) | +11K 0.02% of company | n/a | 11K | n/a | Feb 24, 26 |
Miller Andrew Craig Director | Acquired (grant/award) | +11K 0.02% of company | n/a | 11K | n/a | Feb 24, 26 |
Shaw Christi Officer | Acquired (grant/award) | +54K 0.09% of company | added 100% | 71K | n/a | Jan 12, 26 |
Westlake Biopartners Opportunity Fund I, L.P. Beneficial Owner (10%) | Bought (open market) | +133K 0.2% of company | added 2.9% | 4.66M | $1000K at $7.50 | Dec 18, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Active shelfAt-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing). If $KYTX runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- 12,594,458 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · About $100.0M in size · Priced at $7.94/share
- At-the-market (ATM) program — sells new shares into the market gradually over time · About $100.0M in size
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$KYTX Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$KYTX Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Stocks similar to KYTX
Comparable names in biological products, (no diagnostic substances), closest in size first.
KYTX stock FAQ
Why is $KYTX up today?
Here is the latest on KYTX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for KYTX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the KYTX stock price today?
KYTX last traded at $8.45, up 3.96% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live KYTX alerts?
The KYTX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged KYTX 33 times in the last 30 days.
What exchange is KYTX on?
KYTX (Kyverna Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $521M in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Is KYTX good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge KYTX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.